Novartis Pharma AG: Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs standard-of-care TKIs in adults with newly diagnosed CML
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.